RebeccaA(Emmons)GardnerMD
Pediatric Hematology & Oncology • Seattle, WAInstructor, Pediatrics, University of Washington School of Medicine
Dr. Gardner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-987-2106- Is this information wrong?
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Utah HealthResidency, Pediatrics, 2003 - 2006
University of Maryland School of MedicineClass of 2003
Certifications & Licensure
TN State Medical License 2023 - 2025
WA State Medical License 2006 - 2024
ID State Medical License 2021 - 2023
UT State Medical License 2004 - 2008- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia Start of enrollment: 2012 Mar 25
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Start of enrollment: 2013 Dec 01
- A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia Start of enrollment: 2014 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsChimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, Constance M Yuan, Hao-Wei Wang, Colleen Annesley, Haneen Shalabi, David Stroncek, Terry J Fry, Joerg Krueger, Elad...> ;Transplantation and Cellular Therapy. 2023 Sep 1
- 48 citationsPreinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
- 7 citationsPaving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions...Sarah Nikiforow, Matthew J Frigault, Noelle V Frey, Rebecca A Gardner, Krishna V Komanduri, Miguel-Angel Perales, Partow Kebriaei, Phyllis Irene Warkentin, Marcelo Pas...> ;Transplantation and Cellular Therapy. 2023 Apr 1
- Join now to see all
Abstracts/Posters
- Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T ResistanceRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable ResponsesRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In VivoRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Seattle Children’s Launches CureWorks, a Project Aimed at Revolutionizing Cancer Treatment for KidsJune 12th, 2018
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
